Jon Saxe is a Director at æther THERAPEUTICS. He possess expertise in biopharmaceuticals, biotechnology, lifesciences, pharmaceutical industry, drug development and 27 more skills. Colleagues describe him as "I worked closely with Jon during my 13 years as CFO and VP of Business Development at VistaGen Therapeutics where Jon was Chairperson, and again during my 5 years at Epalex where I was both CFO and CEO with Jon again as Chairman. In those 18 years working closely at the BOD level me and my colleagues (and indirectly our investors) benefitted greatly from his many years of in-depth experience in partnering, financing, licensing and general management, both at small and large-cap companies.", "Jon chaired the Audit Committee of SciClone Pharma while I served the company as external auditor and partner on the account. I’ve since referred Jon for other Board opportunities and we maintain a lifelong friendship. Jon is an “old sage” of the industry and a overflowing wealth of information and insight - studious and a voracious reader, thanks in no small part to his law background, a guy who understands the science a and chemistry of the industry, a well traveled global citizen, and he’s just downright intellectually curious about anything and everything. A convo with Jon can last for hours and range from tennis to patent law to Vitamin C production to orphan drugs. I’m always wow-ed by Jon’s intellectual breadth and depth and eagerness to serve well into advancing age.", and "Jon is a a very broadly experienced professional manager and advisor in the life sciences industry, particularly in recent years with early stage drug companies. He is very bright, highly organized, very dedicated to his responsibilities, and of the greatest integrity. I strongly recommend him for any senior capacity, especially as a Board member."